These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2194748)

  • 1. Reversal of cardiogenic shock and asystole in a septic patient with hypertrophic cardiomyopathy on verapamil.
    Cohen IL; Fein IA; Nabi A
    Crit Care Med; 1990 Jul; 18(7):775-6. PubMed ID: 2194748
    [No Abstract]   [Full Text] [Related]  

  • 2. [Asystole followed by cardiogenic shock after intravenous injection of verapamil].
    Motté G; Bellanger P; Vogel M; Belhassen B; Welti JJ
    Ann Cardiol Angeiol (Paris); 1975; 24(2):157-62. PubMed ID: 1094900
    [No Abstract]   [Full Text] [Related]  

  • 3. Verapamil in hypertrophic cardiomyopathy.
    Am J Cardiol; 1984 May; 53(10):1486-7. PubMed ID: 6539059
    [No Abstract]   [Full Text] [Related]  

  • 4. Asystole and cardiogenic shock due to combined treatment with verapamil and flecainide.
    Buss J; Lasserre JJ; Heene DL
    Lancet; 1992 Aug; 340(8818):546. PubMed ID: 1354292
    [No Abstract]   [Full Text] [Related]  

  • 5. Verapamil: its potential for causing serious complications in patients with hypertrophic cardiomyopathy.
    Epstein SE; Rosing DR
    Circulation; 1981 Sep; 64(3):437-41. PubMed ID: 7196300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiogenic shock following a single therapeutic oral dose of verapamil.
    Stajer D; Bervar M; Horvat M
    Int J Clin Pract; 2001; 55(1):69-70. PubMed ID: 11219325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiogenic shock triggered by verapamil and atenolol: a case report of therapeutic experience with intravenous calcium.
    Sakurai H; Kei M; Matsubara K; Yokouchi K; Hattori K; Ichihashi R; Hirakawa Y; Tsukamoto H; Saburi Y
    Jpn Circ J; 2000 Nov; 64(11):893-6. PubMed ID: 11110438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversible cardiogenic shock in hypertrophic cardiomyopathy after alcohol septal ablation.
    Bensaid A; Dubois-Randé JL; Lim P
    Arch Cardiovasc Dis; 2010; 103(8-9):486-8. PubMed ID: 21074128
    [No Abstract]   [Full Text] [Related]  

  • 9. Reversal of cardiogenic shock and severe mitral regurgitation through verapamil in hypertensive hypertrophic cardiomyopathy.
    Tamborini G; Pepi M; Susini G; Salvi L; Fiorentini C
    Chest; 1993 Jul; 104(1):319-20. PubMed ID: 8325104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of acute systolic dysfunction and cardiogenic shock in hypertrophic cardiomyopathy by surgical relief of obstruction.
    Sherrid MV; Balaran SK; Korzeniecki E; Chaudhry FA; Swistel DG
    Echocardiography; 2011 Oct; 28(9):E174-9. PubMed ID: 21801200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modified release verapamil induced cardiogenic shock.
    Nanda U; Ashish A; Why HJ
    Emerg Med J; 2005 Nov; 22(11):832-3. PubMed ID: 16244356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Verapamil: a cause of sudden death in a patient with hypertrophic cardiomyopathy.
    Perrot B; Danchin N; Terrier de la Chaise A
    Br Heart J; 1984 Mar; 51(3):352-4. PubMed ID: 6538092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium infusion for reversal of adverse effects of intravenous verapamil.
    Morris DL; Goldschlager N
    JAMA; 1983 Jun; 249(23):3212-3. PubMed ID: 6682905
    [No Abstract]   [Full Text] [Related]  

  • 14. Calcium chloride: reassessment of use in asystole.
    Stueven HA; Thompson BM; Aprahamian C; Tonsfeldt DJ
    Ann Emerg Med; 1984 Sep; 13(9 Pt 2):820-2. PubMed ID: 6383139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Verapamil-induced ventricular tachycardia in hypertrophic cardiomyopathy.
    Wessel A; Seiffert P; Dettmann R; Heintzen PH
    Eur Heart J; 1987 Mar; 8(3):313-5. PubMed ID: 3582389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of Doppler echocardiography for determining hemodynamic improvement with intravenous verapamil in hypertrophic cardiomyopathy.
    Cooper M; Shaddy R; Silverman N; Enderlein M
    Am J Cardiol; 1985 Jul; 56(1):201-2. PubMed ID: 4040320
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical and hemodynamic effects of verapamil in hypertrophic obstructive cardiomyopathy].
    Lösse B; Kuhn H; Loogen F
    Z Kardiol; 1982 Dec; 71(12):813-9. PubMed ID: 6891873
    [No Abstract]   [Full Text] [Related]  

  • 18. Verapamil in the treatment of hypertrophic cardiomyopathy.
    Rosing DR; Epstein SE
    Ann Intern Med; 1982 May; 96(5):670-2. PubMed ID: 6122414
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cardiovascular complications during treatment by verapamil. A propos of 6 cases].
    Witchitz S; Haiat R; Tarrade T; Chiche P
    Nouv Presse Med; 1975 Feb; 4(5):337-8. PubMed ID: 236544
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of calcium-channel blocking drugs in hypertrophic cardiomyopathy.
    Rosing DR; Idänpään-Heikkilä U; Maron BJ; Bonow RO; Epstein SE
    Am J Cardiol; 1985 Jan; 55(3):185B-195B. PubMed ID: 3881913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.